The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Open accessAbstract
Activation of hepatic stellate cells in response to chronic inflammation represents a crucial step in the development of liver fibrosis. However, the molecules involved in the interaction between immune cells and stellate cells remain obscure. Herein, we identify the chemokine CCL5 (also known as RANTES), which is induced in murine and human liver after injury, as a central mediator of this interaction. First, we showed in patients with liver fibrosis that CCL5 haplotypes and intrahepatic CCL5 mRNA expression were associated with severe liver fibrosis. Consistent with this, we detected Ccl5 mRNA and CCL5 protein in 2 mouse models of liver fibrosis, induced by either injection of carbon tetrachloride (CCl4) or feeding on a methionine and choline-deficient (MCD) diet. In these models, Ccl5-/- mice exhibited decreased hepatic fibrosis, with reduced stellate cell activation and immune cell infiltration. Transplantation of Ccl5-deficient bone marrow into WT recipients attenuated liver fibrosis, identifying infiltrating hematopoietic cells as the main source of Ccl5. We then showed that treatment with the CCL5 receptor antagonist Met-CCL5 inhibited cultured stellate cell migration, proliferation, and chemokine and collagen secretion. Importantly, in vivo administration of Met-CCL5 greatly ameliorated liver fibrosis in mice and was able to accelerate fibrosis regression. Our results define a successful therapeutic approach to reduce experimental liver fibrosis by antagonizing Ccl5 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
Stephens, M., & Donnelly, P. (2003) · The American Journal of Human Genetics · doi:10.1086/379378 · Cited by 3,513
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Wu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., Sweeney, J. F., Peterson, L. E., Chan, L., Smith, C. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.638379 · Cited by 680
RANTES: a versatile and controversial chemokine
Appay, V., & Rowland-Jones, S. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01812-3 · Cited by 650
Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Self-citationCCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E., & Wells, T. N. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2599 · Cited by 418
Self-citationA Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P.-A., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 383
Schober, A., Manka, D., von Hundelshausen, P., Huo, Y., Hanrath, P., Sarembock, I. J., Ley, K., & Weber, C. (2002) · Circulation · doi:10.1161/01.cir.0000028590.02477.6f · Cited by 355
Self-citationMarra, F., DeFranco, R., Grappone, C., Milani, S., Pastacaldi, S., Pinzani, M., Romanelli, R. G., Laffi, G., & Geñtilini, P. (1998) · Europe PMC (PubMed Central) · Cited by 289
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R., Hellerbrand, C., Keppeler, H., Werth, A., Schirin-Sokhan, R., Wilkens, G., Geier, A., Lorenzen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1599 · Cited by 258
Self-citationHuman Hepatic Stellate Cells Express CCR5 and RANTES to Induce Proliferation and Migration
Schwabe, R. F., Bataller, R., & Brenner, D. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2003 · Cited by 252
Gröne, H., Weber, C., Weber, K. S. C., Gröne, E. F., Rabelink, T., Klier, C. M., Wells, T. N. C., Proudfoot, A. E., Schlondorff, D., & Nelson, P. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1371 · Cited by 241
Self-citationSafadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239
Marra, F., Valente, A. J., Pinzani, M., & Abboud, H. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116753 · Cited by 197
Modulating influence on HIV/AIDS by interacting RANTES gene variants
An, P., Nelson, G. W., Wang, L., Donfield, S. M., Goedert, J. J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W. L., Modi, W. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142313799 · Cited by 194
Hellier, S., Frodsham, A. J., Hennig, B. J. W., Klenerman, P., Knapp, S., Ramaley, P., Satsangi, J., Wright, M., Zhang, L., Thomas, H. C., et al. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.027 · Cited by 192
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Wasmuth, H. E., Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M.-L., Zimmermann, H., Streetz, K. L., Tacke, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.053 · Cited by 168
Self-citationInterleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 167
Self-citationIsolation and Culture of Hepatic Stellate Cells
Weiskirchen, R., & Gressner, A. M. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:099 · Cited by 146
Self-citationLiver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
Holt, A. P., Shepherd, E. L., Lalor, P. F., Filer, A. D., Buckley, C. D., & Adams, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.020 · Cited by 144
Chemokine-directed immune cell infiltration in acute and chronic liver disease
Karlmark, K. R., Wasmuth, H. E., Trautwein, C., & Tacke, F. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.2.233 · Cited by 137
Self-citationImpaired T Cell Function in RANTES-Deficient Mice
Makino, Y., Cook, D. N., Smithies, O., Hwang, O., Neilson, E. G., Turka, L. A., Sato, H., Wells, A. D., & Danoff, T. M. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5178 · Cited by 123
Promrat, K., McDermott, D. H., Gonzalez, C. M., Kleiner, D. E., Koziol, D. E., Lessie, M., Merrell, M. N., Soza, A., Heller, T., Ghany, M. G., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50061 · Cited by 120
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 119
Berres, M., Papen, S., Pauels, K., Schmitz, P., Zaldivar, M. M., Hellerbrand, C., Mueller, T., Berg, T., Weiskirchen, R., Trautwein, C., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.016 · Cited by 92
Self-citationMononuclear cells in liver fibrosis
Marra, F., Aleffi, S., Galastri, S., & Provenzano, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0169-0 · Cited by 90
Ajuebor, M. N., Wondimu, Z., Hogaboam, C. M., Le, T. P., Proudfoot, A. E. I., & Swain, M. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060690 · Cited by 85
Self-citationAjuebor, M. N., Hogaboam, C. M., Le, T. P., Proudfoot, A. E. I., & Swain, M. G. (2004) · European Journal of Immunology · doi:10.1002/eji.200425071 · Cited by 75
Self-citationReversal of Fibrosis: No Longer a Pipe Dream?
Fallowfield, J. A., Kendall, T. J., & Iredale, J. P. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.022 · Cited by 55
Fibrosis and Cirrhosis Reversibility: Clinical Features and Implications
Pinzani, M., & Vizzutti, F. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.006 · Cited by 51
Rangnekar, A. S., Lammert, F., Igolnikov, A., & Green, R. M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01314.x · Cited by 38
Vicente, C. P., Fortuna, V., Margis, R., Trugo, L. C., & Borojević, R. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006886308490 · Cited by 37
Wasmuth, H. E., Matern, S., & Lammert, F. (2004) · Hepatology · doi:10.1002/hep.20150 · Cited by 20
Self-citation
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Metadata
- Authors
- Berres, M.-L., Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., Schmitz, P., Streetz, K. L., Berg, T., Gassler, N., Weiskirchen, R., Proudfoot, A., Weber, C., Trautwein, C., & Wasmuth, H. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-11-01
- Volume
- 120
- Issue
- 11
- Pages
- 4129-4140
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2136547076
- Cited by
- 263
- References
- 41
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.